» Articles » PMID: 31910709

Metabolic Endotoxemia Promotes Neuroinflammation After Focal Cerebral Ischemia

Abstract

Lipopolysaccharide (LPS) is a major component of the outer membrane of Gram-negative bacteria and a potent inflammatory stimulus for the innate immune response via toll-like receptor (TLR) 4 activation. Type 2 diabetes is associated with changes in gut microbiota and impaired intestinal barrier functions, leading to translocation of microbiota-derived LPS into the circulatory system, a condition referred to as metabolic endotoxemia. We investigated the effects of metabolic endotoxemia after experimental stroke with transient middle cerebral artery occlusion (MCAO) in a murine model of type 2 diabetes () and phenotypically normal littermates (). Compared to mice, mice exhibited an altered gut microbial composition, increased intestinal permeability, and higher plasma LPS levels. In addition, mice presented increased infarct volumes and higher expression levels of LPS, TLR4, and inflammatory cytokines in the ischemic brain, as well as more severe neurological impairments and reduced survival rates after MCAO. Oral administration of a non-absorbable antibiotic modulated the gut microbiota and improved metabolic endotoxemia and stroke outcomes in mice; these effects were associated with reduction of LPS levels and neuroinflammation in the ischemic brain. These data suggest that targeting metabolic endotoxemia may be a novel potential therapeutic strategy to improve stroke outcomes.

Citing Articles

Effect of metabolic disorders on reactive gliosis and glial scarring at the early subacute phase of stroke in a mouse model of diabetes and obesity.

Clain J, Couret D, Bringart M, Meilhac O, Lefebvre dHellencourt C, Diotel N IBRO Neurosci Rep. 2025; 18():16-30.

PMID: 39816479 PMC: 11733059. DOI: 10.1016/j.ibneur.2024.12.002.


Novel Insight into the Modulatory Effect of Traditional Chinese Medicine on Cerebral Ischemia-Reperfusion Injury by Targeting Gut Microbiota: A Review.

Ren Y, Chen G, Hong Y, Wang Q, Lan B, Huang Z Drug Des Devel Ther. 2025; 19():185-200.

PMID: 39810832 PMC: 11731027. DOI: 10.2147/DDDT.S500505.


Gut Microbiota, Bacterial Translocation, and Stroke: Current Knowledge and Future Directions.

Granados-Martinez C, Alfageme-Lopez N, Navarro-Oviedo M, Nieto-Vaquero C, Cuartero M, Diaz-Benito B Biomedicines. 2025; 12(12.

PMID: 39767686 PMC: 11673227. DOI: 10.3390/biomedicines12122781.


The Gut Microbiota Modulates Neuroinflammation in Alzheimer's Disease: Elucidating Crucial Factors and Mechanistic Underpinnings.

Yang J, Liang J, Hu N, He N, Liu B, Liu G CNS Neurosci Ther. 2024; 30(10):e70091.

PMID: 39460538 PMC: 11512114. DOI: 10.1111/cns.70091.


Gut Microbiota Mediates Neuroinflammation in Alzheimer's Disease: Unraveling Key Factors and Mechanistic Insights.

Junyi L, Yueyang W, Bin L, Xiaohong D, Wenhui C, Ning Z Mol Neurobiol. 2024; 62(3):3746-3763.

PMID: 39317889 DOI: 10.1007/s12035-024-04513-w.


References
1.
Cani P, Bibiloni R, Knauf C, Waget A, Neyrinck A, Delzenne N . Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes. 2008; 57(6):1470-81. DOI: 10.2337/db07-1403. View

2.
Brun P, Castagliuolo I, Di Leo V, Buda A, Pinzani M, Palu G . Increased intestinal permeability in obese mice: new evidence in the pathogenesis of nonalcoholic steatohepatitis. Am J Physiol Gastrointest Liver Physiol. 2006; 292(2):G518-25. DOI: 10.1152/ajpgi.00024.2006. View

3.
Yamashiro K, Tanaka R, Urabe T, Ueno Y, Yamashiro Y, Nomoto K . Gut dysbiosis is associated with metabolism and systemic inflammation in patients with ischemic stroke. PLoS One. 2017; 12(2):e0171521. PMC: 5293236. DOI: 10.1371/journal.pone.0171521. View

4.
Zrzavy T, Machado-Santos J, Christine S, Baumgartner C, Weiner H, Butovsky O . Dominant role of microglial and macrophage innate immune responses in human ischemic infarcts. Brain Pathol. 2017; 28(6):791-805. PMC: 6334527. DOI: 10.1111/bpa.12583. View

5.
Wiedermann C, Kiechl S, Dunzendorfer S, Schratzberger P, Egger G, Oberhollenzer F . Association of endotoxemia with carotid atherosclerosis and cardiovascular disease: prospective results from the Bruneck Study. J Am Coll Cardiol. 1999; 34(7):1975-81. DOI: 10.1016/s0735-1097(99)00448-9. View